Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices
- PMID: 26920907
- DOI: 10.1007/s12028-016-0254-x
Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices
Abstract
Background: Prolonged systemic antibiotic prophylaxis for central nervous system (CNS) devices may be associated with increased risk of antimicrobial resistance. The primary objective of this study was to determine the impact of prolonged CNS device antibiotic prophylaxis on the growth of resistant microorganisms and Clostridium difficile.
Methods: This retrospective, observational, cohort study included patients admitted to intensive care units with traumatic brain injury or other neurocritical illness. Patients who received a CNS device and antibiotic prophylaxis for at least 72 h were compared to patients with similar neurologic injuries who did not receive a CNS device.
Results: Study (n = 116) and control (n = 557) patients had mean APACHE II scores of 17.7 ± 9.2 and 15.1 ± 10.6 (p = 0.004) with 53.4 and 24.6 % receiving craniotomies (p < 0.001), respectively. Mean CNS device duration was 9.9 days, and 73 % of patients received cefuroxime for prophylaxis. The study cohort had a higher absolute incidence of resistant organisms compared with the control cohort (15.5 vs 4.1 %; odds ratio 1.93, 95 % CI 0.93-4.03, p = 0.078), though the study was underpowered to show statistical significance in multivariate analysis. C. difficile incidence was similar between groups (2.6 vs 2.0 %; odds ratio 1.45, 95 % CI 0.35-6.12, p = 0.61).
Conclusion: We found a higher incidence of resistant organisms in patients receiving prolonged antibiotic prophylaxis with a CNS device, but similar incidence of C. difficile compared to controls. Lack of data supporting prolonged antibiotic prophylaxis for CNS devices and the risk of nosocomial infections with resistant organisms encourage limiting prophylactic antibiotics to a short periprocedural course.
Keywords: Antibiotic prophylaxis; Central nervous system devices; Clostridium difficile; Extraventricular drains; Infections; Intracranial pressure monitor; Resistant organisms; Ventriculitis.
Similar articles
-
Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.J Thorac Cardiovasc Surg. 2016 Feb;151(2):589-97.e2. doi: 10.1016/j.jtcvs.2015.09.090. Epub 2015 Sep 28. J Thorac Cardiovasc Surg. 2016. PMID: 26545971 Free PMC article.
-
Impact of intracranial pressure monitor prophylaxis on central nervous system infections and bacterial multi-drug resistance.Surg Infect (Larchmt). 2008 Oct;9(5):503-8. doi: 10.1089/sur.2007.032. Surg Infect (Larchmt). 2008. PMID: 18687046
-
Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients.Surg Infect (Larchmt). 2006 Oct;7(5):409-17. doi: 10.1089/sur.2006.7.409. Surg Infect (Larchmt). 2006. PMID: 17083307
-
Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?Curr Hematol Malig Rep. 2018 Feb;13(1):59-67. doi: 10.1007/s11899-018-0435-0. Curr Hematol Malig Rep. 2018. PMID: 29374371 Free PMC article. Review.
-
Central Nervous System Device Infections.Curr Infect Dis Rep. 2016 Nov;18(11):34. doi: 10.1007/s11908-016-0541-x. Curr Infect Dis Rep. 2016. PMID: 27686676 Review.
Cited by
-
Concentrations of Cefuroxime in Brain Tissue of Neurointensive Care Patients.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e02164-17. doi: 10.1128/AAC.02164-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29203481 Free PMC article.
-
The intestinal microbiome and surgical disease.Curr Probl Surg. 2016 Jun;53(6):257-93. doi: 10.1067/j.cpsurg.2016.06.001. Epub 2016 Jun 14. Curr Probl Surg. 2016. PMID: 27497246 Free PMC article. Review. No abstract available.
-
Ventriculitis: Infection or Inflammation.Antibiotics (Basel). 2021 Oct 14;10(10):1246. doi: 10.3390/antibiotics10101246. Antibiotics (Basel). 2021. PMID: 34680826 Free PMC article. Review.
-
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13. Infect Dis Ther. 2024. PMID: 38349594 Free PMC article. Review.
-
The gut microbiota and gastrointestinal surgery.Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):43-54. doi: 10.1038/nrgastro.2016.139. Epub 2016 Oct 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27729657 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical